Clinical trial
Development and Validation of an AI-Based Wound Alert System With a Home-Based Management Model for a Diabetic Foot Recurrence Cohort
NCT07452354 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Development and Validation of an AI-Based Wound Alert System With a Home-Based Management Model for a Diabetic Foot Recurrence Cohort
- Lead sponsor
- Peking University Third Hospital
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- March 15, 2026
- Completion date
- December 31, 2028
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
artificial intelligence (ai) in diagnosis, diabete mellitus, diabetic foot ulcer (dfu), diabetic foot ulcer treatment